Product Liability

Tamiflu Fraud Bilked $1.5 Billion from Government, Alleges Whistleblower

Lawsuit: Roche Pharma misrepresented flu drug’s ability to contain influenza pandemic

BALTIMORE – Drug company Hoffmann-La Roche (OTCMKTS – RHHBY) bilked U.S. federal and state governments out of $1.5 billion by misrepresenting clinical studies and falsely claiming that its well-known influenza medicine Tamiflu was effective at containing potential pandemics, according to a recently unsealed whistleblower lawsuit. 
Continue reading “Tamiflu Fraud Bilked $1.5 Billion from Government, Alleges Whistleblower”

Pinnacle Hip Lawsuit

Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case

DePuy/J&J Orthopaedics found liable for metal-on-metal implant failures

DALLAS – A federal court jury in Texas returned a $247 million verdict on behalf of six people who suffered serious medical complications caused by the defective metal-on-metal hip implants made by Johnson & Johnson (NYSE: JNJ) and its subsidiary DePuy/J&J Orthopaedics Inc. Continue reading “Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case”

Juries Return Multi-Million Dollar Verdicts in Defective DePuy/J&J Hip Implants Lawsuits

Attorney Mark Lanier: Trials send strong message of accountability to Johnson & Johnson

DALLAS – In 2016, two federal juries in Dallas delivered significant verdicts on behalf of the victims of serious medical complications caused by defective metal-on-metal hip implants made by Johnson & Johnson (NYSE: JNJ) and its subsidiary DePuy/J&J Orthopaedics Inc.

Continue reading “Juries Return Multi-Million Dollar Verdicts in Defective DePuy/J&J Hip Implants Lawsuits”

EpiPen Maker Mylan Hit With Class-Action Lawsuit

Lawsuit seeks damages for Mylan’s unconscionable sales tactics

HOUSTON – A class-action lawsuit filed against pharmaceutical giant Mylan Inc. (NASDAQ: MYL) seeks damages for consumers victimized by the company’s cutthroat sales and marketing tactics related to controversial price increases for Mylan’s EpiPen injectors.

The lawsuit filed by The Lanier Law Firm and Sharp Law on behalf of consumers who have purchased EpiPen injectors charges that Mylan began a series of aggressive price increases shortly after it acquired the rights to sell the EpiPen in 2007. Mylan required consumers to purchase the EpiPen in pairs and raised the retail price from $57 in 2007 to more than $600 today, even though pharmaceutical industry sources estimate each injector can be produced for less than $30.

Continue reading “EpiPen Maker Mylan Hit With Class-Action Lawsuit”